Stocks Clock Fourth...
Health Care: Drugs
Oncothyreon Inc. (ONTY: NASDAQ)
$1.99 0.02 | 1.02%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.99 |
| 52 Week High | 6.24 |
| 52 Week Low | 1.71 |
| Avg. Daily Vol. (Mil) | 0.83 |
| Beta (3 year) | 1.01 |
| Share Related Items | |
| Mkt Cap (Mil) | 113.86 |
| Shares Out (Mil) | 57.22 |
| Float (Mil) | 57.01 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 18.00 |
| Current Ratio | 18.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 1.53 |
| Price/Cash Flow | -10.20 |
| Per Share Data | |
| Earnings | -0.83 |
| Sales | 0.00 |
| Book Value | 1.30 |
| Cash Flow | -0.19 |
| Business Summary | |
|---|---|
| Oncothyreon Inc., is a clinical-stage biopharmaceutical company. It develops and markets synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients. | |
| General Information | |
| 2601 Fourth Avenue
Suite 500 Seattle, WA 98121 |
|
| www.oncothyreon.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 42 | |
| CEO: Dr. Robert L. Kirkman, M | |
| Short Interest | |
| Current Month (Mil) | 7.72 |
| Previous Month (Mil) | 7.38 |
| Short Interest Ratio (Days) | 11.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -14.20 |
| Return on Investments | -15.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ONTY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorBreakout Stocks Of The Week...
Latest ONTY Headlines from TheStreet
- ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine 05.15.13 | 06:05 pm
- 4 Biotech Stocks Under $10 Making Big Moves 04.09.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 3 Pharma Stocks Leaping on Unusual Volume 01.10.13 | 02:01 pm
- Biotech Stock Mailbag: Amicus, Amarin, Oncothyreon 12.21.12 | 07:12 am
- Stocks Slip as Pessimism Clouds Fiscal-Cliff Talks 12.19.12 | 02:12 pm
- Oncothyreon: A Failed Drug Autopsy Performed By A Short Seller 12.19.12 | 10:12 am
- Stock Futures Rise Ahead of Housing Data 12.19.12 | 07:12 am
- Merck KGaA, Oncothyreon Lung Cancer Drug Fails Late-Stage Study 12.19.12 | 06:12 am
- 4 More Stocks Leaping on Unusual Volume 12.11.12 | 03:12 pm
Press Releases for ONTY
- Oncothyreon Announces Data For L-BLP25 And PX-866 To Be Presented At American Society Of Clinical Oncology Meeting - PR Newswire 05.16.13 | 06:05 am
- Oncothyreon Announces First Quarter 2013 Financial Results Conference Call - PR Newswire 05.02.13 | 08:05 am
- Oncothyreon To Present At Future Leaders In The Biotech Industry Conference - PR Newswire 03.29.13 | 08:03 am
- Oncothyreon Announces Full Year And Fourth Quarter 2012 Financial Results Conference Call - PR Newswire 03.07.13 | 08:03 am
- Oncothyreon To Present At Cowen And Company 33rd Annual Health Care Conference - PR Newswire 02.27.13 | 08:02 am
- Oncothyreon Announces That L-BLP25 (Stimuvax®) Did Not Meet Primary Endpoint Of Improvement In Overall Survival In Pivotal Phase 3 Trial In Patients With Non-Small Cell Lung Cancer - PR Newswire 12.19.12 | 06:12 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In November 2012 - PR Newswire 11.07.12 | 08:11 am
- Oncothyreon Announces Third Quarter 2012 Financial Results Conference Call - PR Newswire 10.31.12 | 08:10 am
- Oncothyreon Expands Phase 2 Trial Of Its PI-3 Kinase Inhibitor PX-866 In Patients With Prostate Cancer - PR Newswire 09.05.12 | 08:09 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In September 2012 - PR Newswire 08.29.12 | 08:08 am
Partner Headlines for ONTY
- Stock Watch Thursday, 20 December - Seeking Alpha 12.20.12 | 09:12 am
- Long term spread targets Oncothyreon - NASDAQ 08.30.12 | 04:08 pm
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting - Benzinga 06.02.12 | 06:06 pm
- Must Know Equity Upgrades and Downgrades Wednesday - Wall St. Cheat Sheet 05.23.12 | 03:05 am
- Interesting Reaction To Oncothyreon's Share Offering - Seeking Alpha 03.30.12 | 08:03 am
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Oncothyreon And Lpath: Shares Collapsed, Primed For A Rebound? - Seeking Alpha 03.09.12 | 09:03 am
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
- Stocks To Watch Week Of Feb. 6 - Seeking Alpha 02.06.12 | 08:02 am
